Opthea To Present at H.C. Wainwright Annual Global Life Sciences Conference
Dr Megan Baldwin, the Company’s Chief Executive Officer, will present at H.C. Wainwright Annual Global Life Sciences Conference May 23-25.
WebcastOpthea To Present at Citi Biopharma Virtual Co-Panel day
Dr Megan Baldwin, the Company’s Chief Executive Officer, will present on the Citi Biopharma virtual Co-Panel day Ophthalmology Panel on May 18, 2022
WebcastARVO 2022 Annual Meeting
Opthea Presented Efficacy and Safety of OPT-302 in combination with Ranibizumab for Polypoidal Choroidal Vasculopathy at ARVO 2022
Poster PresentationASX Small – Mid Cap Conference 2022
Opthea Presented at the ASX Small – Mid Cap Conference 2022
Oppenheimer’s 32nd Annual Healthcare Conference
Opthea to Present at the Oppenheimer Annual Healthcare Conference – webcast on Tuesday, March 15 at 8:40 am ET
WebcastAngiogenesis 2022 – Prof Cheung presentation of PCV data
OPT-302 Combination Therapy in Polypoidal Choroidal Vasculopathy.
Download PDF
SVB Leerink 11th Annual Healthcare Conference
Opthea to present at the SVB Leerink 11th Annual Healthcare Conference — webcast on Thursday, February 17 at 2:20 pm ET (Friday, February 18, 6:20 am AEDT)
Webcast
H.C. Wainwright BIOCONNECT Conference
Opthea to present at the H.C. Wainwright BIOCONNECT Conference — webcast on Monday, January 10 at 7:00 am ET (Monday, January 10, 11:00 pm AEDT)
Webcast
6 September 2019
6 November 2018 in New York
6 September 2019
6 November 2018 in New York